Quarterly report pursuant to Section 13 or 15(d)

3. ACQUISITION (Details)

v3.8.0.1
3. ACQUISITION (Details)
9 Months Ended
Sep. 30, 2017
USD ($)
Acquisition Details  
Issuance of 12,886,740 shares of common stock (voting and non-voting) valued at $3.66 per share $ 47,165,468
Transfer of two plasma collection centers 12,621,844
Total purchase price $ 59,787,312